2011
DOI: 10.1002/dat.20572
|View full text |Cite
|
Sign up to set email alerts
|

Successful use of continuous renal replacement therapy after hydroxocobalamin administration

Abstract: A new gas‐phase technology for polyolefin production is being developed to be commercially available for large‐scale production between 2004 and 2005. This new technology uses a multizone circulating reactor, which consists of two interrelated zones where two distinct and different fluodynamic regimes are realized, between which the polymer particles are kept in continuous circulation. In the first part, we presented a mathematical model for the reactor, and this second part of the article we present simulatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(18 citation statements)
references
References 38 publications
0
18
0
Order By: Relevance
“…A further problem caused by hydroxocobalamin's pigment is false triggering of the sensor that detects blood leakage across the artificial kidney membrane during dialysis. This problem has been circumvented by recalibrating this sensor using a continuous renal replacement machine 71 …”
Section: Resultsmentioning
confidence: 99%
“…A further problem caused by hydroxocobalamin's pigment is false triggering of the sensor that detects blood leakage across the artificial kidney membrane during dialysis. This problem has been circumvented by recalibrating this sensor using a continuous renal replacement machine 71 …”
Section: Resultsmentioning
confidence: 99%
“…11 Gambro Phoenix X36, NxStage, and Prisma Flex dialysis machines are reported to be not affected by this dialysate discoloration due to hydroxocobalamin and can be safely used for dialysis in such patients. 8,11,12…”
Section: Discussionmentioning
confidence: 99%
“…Initial reports suggested Cyanokit administration was safe prior to organ transplantation [ 18 ]. However, more recent reports have found hydroxocobalamin to be associated with failure of intermittent hemodialysis, thus limiting the opportunity to provide life-saving treatment should a transplanted allograft fail or experience delayed function [ 19 , 20 ]. The presumed mechanism for this phenomenon is the discoloration of bodily fluids triggering a “pseudo-blood leak” [ 21 ].…”
Section: Discussionmentioning
confidence: 99%